GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (7-36) amide (GLP-1) is an insulin secretagogue. Recently, many studies have shown GLP-1 can improve insulin resistance in peripheral tissues. In the present study, we investigated glucose uptake in 3T3-L1 adipocytes in either basal or insulin resistant state and dissected insulin signaling pathway in order to elucidate the molecular mechanisms of GLP-1 mediated improvement of insulin resistance. We found GLP-1 and its long lasting analogue, exendin 4 up-regulated basal IR, IRS-1 and Glut 4 expressions although they did not increase basal glucose uptake alone. However, GLP-1 and exendin-4 increased insulin mediated glucose uptake in intact and TNF-alpha treated 3T3-L1 adipocytes by up-regulation of phophorylated IRbeta, IRS-1, Akt and GSK-3beta. These results indicate that GLP-1 and its analogue exendin-4 can amplify insulin signaling in 3T3-L1 adipocytes by up-regulation of some crucial insulin signaling molecules.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This enhanced intracellular lipid storage and insulin-mediated glucose uptake promoting intracellular lipid storage and insulin-mediated glucose uptake via the up-regulation of GLUT4 expression and phosphorylation of the insulin receptor in adipose cells [65].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [65]
Citations
Cites
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Stoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., & Egan, J. M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.741 · Cited by 576
Stephens, J. M., Lee, J., & Pilch, P. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.971 · Cited by 553
Suppressor of Cytokine Signaling 3 Is a Physiological Regulator of Adipocyte Insulin Signaling
Shi, H., Tzameli, I., Bjørbæk, C., & Flier, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403886200 · Cited by 222
Li, L., El-Kholy, W., Rhodes, C. J., & Brubaker, P. L. (2005) · Diabetologia · doi:10.1007/s00125-005-1787-2 · Cited by 206
Fujishiro, M., Gotoh, Y., Katagiri, H., Sakoda, H., Ogihara, T., Anai, M., Onishi, Y., Ono, H., Abe, M., Shojima, N., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0131 · Cited by 184
GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor
Yang, H., Egan, J. M., Wang, Y., Moyes, C. D., Roth, J., Montrose, M. H., & Montrose-Rafizadeh, C. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.3.c675 · Cited by 136
D'Alessio, D. A., Prigeon, R. L., & Ensinck, J. W. (1995) · Diabetes · doi:10.2337/diab.44.12.1433 · Cited by 122
Egan, J. M. (1994) · Endocrinology · doi:10.1210/en.135.5.2070 · Cited by 121
Research works printed but not linked: 1
- J.M. Egan, C. Montrose-Rafizadeh, Y. Wang et al. Endocrinology 135, 2070–2075 (1994) · doi:10.1210/endo.135.5.7956929 · Paper page
Cited by
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“(Wang et al., 1997a; Gao et al., 2007).”
BackgroundGlucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
Armstrong, M. J., Hull, D., Guo, K., Barton, D., Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Yu, J., Gough, S. C., Newsome, P. N., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.038 · Cited by 456
Lee, Y.-S., Park, M.-S., Choung, J.-S., Kim, S.-S., Oh, H.-H., Choi, C.-S., Ha, S.-Y., Kang, Y., Kim, Y., & Jun, H.-S. (2012) · Diabetologia · doi:10.1007/s00125-012-2592-3 · Cited by 319
“Further studies on mechanisms by which GLP-1 improves insulin sensitivity have shown that treatment of 3T3-L1 adipocytes with exendin-4, a GLP-1 receptor agonist, increases insulin-stimulated glucose uptake [13] and amplifies insulin signalling by upregulating basal insulin receptor, IRS-1 and GLUT4 abundance [14].”
BackgroundThe role of type 2 diabetes in neurodegeneration
Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 272
Metadata
- Authors
- Gao, H., Wang, X., Zhang, Z., Yang, Y., Yang, J., Li, X., & Ning, G.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Li, Xiaoying
- Ning, Guang
- Venue
- Endocrine
- Published
- 2007-10-02
- Volume
- 32
- Issue
- 1
- Pages
- 90-95
- ISSN
- 0969-711X (ISSN-L)
- 1559-0100
- OpenAlex
- W2041501810
- Cited by
- 77
- References
- 22
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 1 · 2017: 7 · 2016: 2 · 2015: 5 · 2014: 7 · 2013: 5 · 2012: 7
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Endocrine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Shanghai Municipal Education Commission
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucagon-like peptide-1, exendin-4, insulin signaling, insulin resistance, insulin receptor beta, IRS-1, GLUT4, glucose uptake, adipocytes, TNF-α, Akt, GSK3β, insulin secretagogues
- MeSH terms
- Exenatide, Animals, Glucose, Insulin, Peptides, Receptor, Insulin, Tumor Necrosis Factor-alpha, Venoms, Signal Transduction, Up-Regulation, Adipocytes, 3T3-L1 Cells, Adaptor Proteins, Signal Transducing, Glucose Transporter Type 4, Mice, Glucagon-Like Peptide 1, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes. https://app.cochat.ai/papers/10.1007/s12020-007-9011-4
- The paper
- Gao, H., Wang, X., Zhang, Z., Yang, Y., Yang, J., Li, X., & Ning, G. (2007). GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes. Endocrine. https://doi.org/10.1007/s12020-007-9011-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.